Juan E. Naves

434 total citations
17 papers, 198 citations indexed

About

Juan E. Naves is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Juan E. Naves has authored 17 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Genetics and 7 papers in Surgery. Recurrent topics in Juan E. Naves's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (6 papers) and Hepatitis B Virus Studies (3 papers). Juan E. Naves is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (6 papers) and Hepatitis B Virus Studies (3 papers). Juan E. Naves collaborates with scholars based in Spain. Juan E. Naves's co-authors include Eugeni Domènech, Eduard Cabré, Míriam Mañosa, Jordi Guardiola, Esther García-Planella, Alexandra Ruiz‐Cerulla, Yamile Zabana, Alejandro Olivé, Jordina Llaó and Isabel Badell and has published in prestigious journals such as Gastroenterology, PLoS ONE and The American Journal of Gastroenterology.

In The Last Decade

Juan E. Naves

16 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan E. Naves Spain 9 103 97 75 42 39 17 198
Mireia Peñalva Spain 6 217 2.1× 170 1.8× 121 1.6× 36 0.9× 19 0.5× 16 300
Bénédicte De Vroey France 8 128 1.2× 131 1.4× 95 1.3× 23 0.5× 30 0.8× 17 312
Antonio López-Sanromán Spain 8 90 0.9× 76 0.8× 73 1.0× 32 0.8× 20 0.5× 12 209
Maria de Lourdes Abreu Ferrari Brazil 7 96 0.9× 102 1.1× 91 1.2× 20 0.5× 52 1.3× 17 229
Mohamed Attauabi Denmark 8 156 1.5× 105 1.1× 62 0.8× 12 0.3× 26 0.7× 42 252
G. Radford‐Smith Australia 5 68 0.7× 66 0.7× 47 0.6× 18 0.4× 11 0.3× 9 168
Laura Cantoro Italy 8 113 1.1× 88 0.9× 76 1.0× 20 0.5× 14 0.4× 10 178
P. Hindryckx Belgium 4 94 0.9× 96 1.0× 43 0.6× 13 0.3× 8 0.2× 4 152
Paul Bus Netherlands 7 140 1.4× 73 0.8× 24 0.3× 20 0.5× 32 0.8× 9 302
Anthony Croft Australia 9 245 2.4× 203 2.1× 77 1.0× 26 0.6× 13 0.3× 17 324

Countries citing papers authored by Juan E. Naves

Since Specialization
Citations

This map shows the geographic impact of Juan E. Naves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan E. Naves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan E. Naves more than expected).

Fields of papers citing papers by Juan E. Naves

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan E. Naves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan E. Naves. The network helps show where Juan E. Naves may publish in the future.

Co-authorship network of co-authors of Juan E. Naves

This figure shows the co-authorship network connecting the top 25 collaborators of Juan E. Naves. A scholar is included among the top collaborators of Juan E. Naves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan E. Naves. Juan E. Naves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Iglesias, Marta, et al.. (2025). Oesophageal Lichen Planus: Case Series and Review of the Literature. Acta Dermato Venereologica. 105. adv43358–adv43358.
2.
Barba, Elizabeth, et al.. (2022). Benefit of extending the protocol for high resolution manometry according to the version 4.0 of the Chicago criteria. A multicenter study. Neurogastroenterology & Motility. 35(3). e14503–e14503. 3 indexed citations
3.
Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2020). Fendrix vs Engerix-B for Primo-Vaccination Against Hepatitis B Infection in Patients With Inflammatory Bowel Disease: A Randomized Clinical Trial. The American Journal of Gastroenterology. 115(11). 1802–1811. 14 indexed citations
4.
Lorén, Violeta, Juan E. Naves, Míriam Mañosa, et al.. (2018). ANP32E, a Protein Involved in Steroid-Refractoriness in Ulcerative Colitis, Identified by a Systems Biology Approach. Journal of Crohn s and Colitis. 13(3). 351–361. 34 indexed citations
5.
Latorre, Irene, J.M. Carrascosa, Juan E. Naves, et al.. (2017). Immune-mediated inflammatory diseases differently affect IGRAs’ accuracy for latent tuberculosis infection diagnosis in clinical practice. PLoS ONE. 12(12). e0189202–e0189202. 15 indexed citations
6.
Llaó, Jordina, Juan E. Naves, Alexandra Ruiz‐Cerulla, et al.. (2016). Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies. Digestive and Liver Disease. 48(6). 608–612. 15 indexed citations
8.
Naves, Juan E., Jordina Llaó, Alexandra Ruiz‐Cerulla, et al.. (2014). Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks. Inflammatory Bowel Diseases. 20(8). 1375–1381. 22 indexed citations
9.
Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2014). Mo1740 Prospective, Randomized Clinical Trial Comparing the Efficacy of Two Vaccines Against Hepatitis B Virus (HBV) in Inflammatory Bowel Disease (IBD) Patients. Gastroenterology. 146(5). S–648. 3 indexed citations
10.
Llaó, Jordina, Juan E. Naves, Alexandra Ruiz‐Cerulla, et al.. (2014). Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids. Journal of Crohn s and Colitis. 8(11). 1523–1528. 16 indexed citations
11.
Chaparro, María, Jordi Gordillo, Eugeni Domènech, et al.. (2014). P372 Prospective, randomized clinical trial comparing the efficacy of two vaccines against hepatitis B virus (HBV) in inflammatory bowel disease (IBD) patients. Journal of Crohn s and Colitis. 8. S220–S221. 1 indexed citations
12.
Naves, Juan E., et al.. (2013). A Systematic Review of SAPHO Syndrome and Inflammatory Bowel Disease Association. Digestive Diseases and Sciences. 58(8). 2138–2147. 29 indexed citations
13.
Naves, Juan E., Alexandra Ruiz‐Cerulla, Jordi Gordillo, et al.. (2013). P439 Management and outcome of severe attacks of ulcerative colitis in the era of biologicals. Journal of Crohn s and Colitis. 7. S186–S186. 1 indexed citations
14.
Naves, Juan E. & Eugeni Domènech. (2011). Amiloidosis sistémica en la enfermedad inflamatoria intestinal. Gastroenterología y Hepatología. 35(4). 259–265. 4 indexed citations
15.
Naves, Juan E., Vicente Lorenzo‐Zúñiga, Laura Marín, et al.. (2011). Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice.. PubMed. 20(4). 355–8. 12 indexed citations
16.
Naves, Juan E., et al.. (2010). Hipertensión portal en pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología. 33(4). 297–302. 1 indexed citations
17.
Badell, Isabel, Míriam Mañosa, Juan E. Naves, et al.. (2009). Systemic amyloidosis in inflammatory bowel disease: Retrospective study on its prevalence, clinical presentation, and outcome. Journal of Crohn s and Colitis. 4(3). 269–274. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026